Rouven Bergmann Sells 2,000 Shares of Medidata Solutions Inc (NASDAQ:MDSO) Stock

Medidata Solutions Inc (NASDAQ:MDSO) CFO Rouven Bergmann sold 2,000 shares of the firm’s stock in a transaction dated Tuesday, December 19th. The shares were sold at an average price of $65.95, for a total value of $131,900.00. Following the transaction, the chief financial officer now directly owns 89,775 shares of the company’s stock, valued at approximately $5,920,661.25. The sale was disclosed in a document filed with the Securities & Exchange Commission, which can be accessed through this link.

Rouven Bergmann also recently made the following trade(s):

  • On Thursday, November 30th, Rouven Bergmann sold 2,000 shares of Medidata Solutions stock. The shares were sold at an average price of $65.40, for a total value of $130,800.00.

Shares of Medidata Solutions Inc (MDSO) opened at $65.84 on Friday. The stock has a market capitalization of $3,850.00, a PE ratio of 94.06, a P/E/G ratio of 3.36 and a beta of 1.69. The company has a debt-to-equity ratio of 0.61, a current ratio of 1.29 and a quick ratio of 3.37. Medidata Solutions Inc has a one year low of $47.77 and a one year high of $85.92.

Medidata Solutions (NASDAQ:MDSO) last posted its quarterly earnings results on Thursday, October 26th. The company reported $0.33 earnings per share for the quarter, topping the Zacks’ consensus estimate of $0.31 by $0.02. Medidata Solutions had a return on equity of 11.54% and a net margin of 7.84%. The company had revenue of $140.08 million during the quarter, compared to the consensus estimate of $141.27 million. During the same period last year, the business earned $0.28 EPS. The business’s quarterly revenue was up 16.7% on a year-over-year basis. analysts predict that Medidata Solutions Inc will post 0.78 earnings per share for the current year.

Several institutional investors and hedge funds have recently bought and sold shares of the company. 1st Global Advisors Inc. raised its stake in shares of Medidata Solutions by 0.5% during the 2nd quarter. 1st Global Advisors Inc. now owns 8,243 shares of the company’s stock worth $645,000 after purchasing an additional 37 shares in the last quarter. State Board of Administration of Florida Retirement System raised its stake in shares of Medidata Solutions by 0.3% during the 2nd quarter. State Board of Administration of Florida Retirement System now owns 33,828 shares of the company’s stock worth $2,645,000 after purchasing an additional 109 shares in the last quarter. Pinebridge Investments L.P. raised its stake in shares of Medidata Solutions by 2.1% during the 2nd quarter. Pinebridge Investments L.P. now owns 7,305 shares of the company’s stock worth $572,000 after purchasing an additional 153 shares in the last quarter. Zurcher Kantonalbank Zurich Cantonalbank raised its stake in shares of Medidata Solutions by 10.5% during the 2nd quarter. Zurcher Kantonalbank Zurich Cantonalbank now owns 2,186 shares of the company’s stock worth $171,000 after purchasing an additional 208 shares in the last quarter. Finally, PNC Financial Services Group Inc. raised its stake in shares of Medidata Solutions by 0.6% during the 2nd quarter. PNC Financial Services Group Inc. now owns 82,279 shares of the company’s stock worth $6,435,000 after purchasing an additional 526 shares in the last quarter. 97.52% of the stock is owned by institutional investors.

Several brokerages have recently commented on MDSO. KeyCorp reaffirmed a “buy” rating and set a $86.00 target price on shares of Medidata Solutions in a report on Sunday, September 17th. Royal Bank of Canada began coverage on Medidata Solutions in a report on Tuesday, September 19th. They set a “sector perform” rating and a $82.00 target price for the company. Zacks Investment Research raised Medidata Solutions from a “sell” rating to a “hold” rating in a report on Wednesday, September 20th. SunTrust Banks reaffirmed a “buy” rating and set a $92.00 target price on shares of Medidata Solutions in a report on Friday, October 27th. Finally, Wells Fargo & Co reduced their target price on Medidata Solutions from $83.00 to $80.00 and set a “market perform” rating for the company in a report on Friday, October 27th. One analyst has rated the stock with a sell rating, three have given a hold rating and eleven have given a buy rating to the stock. Medidata Solutions presently has a consensus rating of “Buy” and an average price target of $84.54.

WARNING: “Rouven Bergmann Sells 2,000 Shares of Medidata Solutions Inc (NASDAQ:MDSO) Stock” was originally posted by Week Herald and is the sole property of of Week Herald. If you are viewing this news story on another site, it was illegally copied and republished in violation of U.S. and international copyright & trademark legislation. The original version of this news story can be accessed at https://weekherald.com/2018/01/12/medidata-solutions-inc-mdso-cfo-rouven-bergmann-sells-2000-shares.html.

About Medidata Solutions

Medidata Solutions Inc (Medidata) is a provider of cloud-based solutions for life sciences. The Company provides cloud-based solutions for clinical research in life sciences, offering platform technology that focuses on the clinical development. The Company’s plan study addresses three areas to ensure optimal study design, grant development and negotiation, and investigator payments.

Insider Buying and Selling by Quarter for Medidata Solutions (NASDAQ:MDSO)

Receive News & Ratings for Medidata Solutions Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Medidata Solutions and related companies with MarketBeat.com's FREE daily email newsletter.

Leave a Reply